Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque

<i>Background and Objectives</i>: Atherosclerosis is a disease in the pathogenesis of which plasma factors apart from elevated cholesterol levels play a keyrole. Such factors include osteopontin (OPN), osteoprotegerin (OPG), and metalloproteinases (MMPs), which are factors that may be re...

Full description

Bibliographic Details
Main Authors: Michał Kosowski, Marcin Basiak, Marcin Hachuła, Bogusław Okopień
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Medicina
Subjects:
PCSK-9 inhibitors
atherosclerotic plaque
dyslipidemia
osteopontin
osteoprotegerin
metalloproteinase 2
Online Access:https://www.mdpi.com/1648-9144/58/7/969

Similar Items

Similar Items